Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Tissue Repair Ltd ( (AU:TRP) ) just unveiled an update.
Tissue Repair Limited has announced the appointment of Stantons International Audit and Consulting Pty Ltd as its new auditor, following the resignation of Pitcher Partners Sydney. This change, approved at the company’s Annual General Meeting, aligns with compliance requirements and has received necessary regulatory approvals. The appointment is expected to support the company’s ongoing operations and strategic goals.
More about Tissue Repair Ltd
Tissue Repair Limited (ASX: TRP) is a Phase 3 biotechnology company focused on developing advanced wound healing agents. The company is progressing its lead drug candidate TR987® for chronic wounds and is also commercializing TR Pro+®, a topical treatment aimed at enhancing healing and skin quality post-cosmetic or medical procedures. Their proprietary Glucoprime® API supports a growing pipeline of therapeutic solutions.
Average Trading Volume: 100,263
Technical Sentiment Signal: Buy
Current Market Cap: A$17.23M
See more data about TRP stock on TipRanks’ Stock Analysis page.